Discussions, summarized Sumcast distills Slack conversations, Reddit discussions and more into a concise daily newsletter that only takes a few minutes to read. Or, listen to it in your favorite podcast app.
Hacker News1 Java4Shell: RCE in OpenJDK when processing Base64A researcher describes discovering a memory corruption flaw in the Base64 decoder of OpenJDK, which was used to build a remote exploit chain. The chain leads to heap data disclosure and, ultimately, remote code execution. Exploitability and real-world risk: Remote heap grooming is sensitive to network conditions and needs bespoke per-target profiles, so mass exploitation seems unlikely near-term. Commenters still expect LLMs to speed exploit development, and high-value targets like Keycloak are a concern.Mitigations and affected configurations: The bug only affects x86-64 hosts with AVX-512 features. Suggested workarounds are -XX:-UseBASE64Intrinsics or disabling AVX-512, and proxies that buffer request bodies may reduce risk. Some JRE8 builds are reported affected.Slow patching by Java distributions: Eclipse Temurin had not released a patch hours after disclosure, while Azul and Corretto fixed it quickly. Commenters noted Temurin's advance-notice gap as a reason for the delay.
Reddit science1 Researchers have developed experimental mRNA nose drops that bypass the blood-brain barrier to restore memory and boost new neuron growth in aging and Alzheimer's-model mice by prompting nasal cells to produce a vital brain protein called BDNF.Researchers at the University of Sydney developed a nasal drop that uses mRNA in lipid nanoparticles to make mice's noses produce brain-derived neurotrophic factor (BDNF), which bypasses the blood-brain barrier. In aged and Alzheimer's model mice, it improved memory and boosted new neuron markers, though it did not reduce amyloid plaques. Human trials may begin within two years. Comparison with existing BDNF boosters: Commenters asked whether this beats nootropics and entheogens that raise BDNF. Replies argued its main advantage is controlled, targeted delivery with fewer systemic side effects, since the tracer study showed mRNA-LNP stayed in the nasal cavity and brain.Human applicability and duration of effect: Users noted the results are only in mice and may never reach humans, with anatomical differences a concern. Another said mRNA degrades quickly, so effects likely won't last long and it may work best as part of a combination therapy.Personal memory concerns and seizure risk: Users with epilepsy, TBI, and memory problems asked whether it could help. One reply said BDNF mainly aids forming new connections, and another warned that raised BDNF could trigger neuronal bursts and seizures in epilepsy patients.
Create your own,personal Sumcast